Benilde Cosmi
309 works · 9,833 citations · h-index 48
Top works
- d -Dimer Testing to Determine the Duration of Anticoagulation Therapy
- Low-molecular-weight heparins and unfractionated heparin in the treatment of patients with acute venous thromboembolism: Results of a meta-analysis
- Risk of Venous Thromboembolism Recurrence: High Negative Predictive Value of D-dimer Performed after Oral Anticoagulation Is Stopped
- Bleeding with anticoagulation therapy – Who is at risk, and how best to identify such patients
- Predictive Value of D-Dimer Test for Recurrent Venous Thromboembolism After Anticoagulation Withdrawal in Subjects With a Previous Idiopathic Event and in Carriers of Congenital Thrombophilia
- Categorization of patients as having provoked or unprovoked venous thromboembolism: guidance from the SSC of ISTH
- Diagnosis and treatment of disseminated intravascular coagulation: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET)
- Comparison between different D ‐ D imer cutoff values to assess the individual risk of recurrent venous thromboembolism: analysis of results obtained in the DULCIS study
- Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis
- Meta-Analysis of Trials Comparing Oral Anticoagulation and Aspirin versus Dual Antiplatelet Therapy after Coronary Stenting
- Comparison of the Non-Specific Binding of Unfractionated Heparin and Low Molecular Weight Heparin (Enoxaparin) to Plasma Proteins
- D-dimer to guide the duration of anticoagulation in patients with venous thromboembolism: a management study
- The Comparative Effects of Recombinant Hirudin (CGP 39393) and Standard Heparin on Thrombus Growth in Rabbits
- Usefulness of repeated D-dimer testing after stopping anticoagulation for a first episode of unprovoked venous thromboembolism: the PROLONG II prospective study
- High thrombin generation measured in the presence of thrombomodulin is associated with an increased risk of recurrent venous thromboembolism
- A Randomised, Double-Blind, Placebo-Controlled Trial of Dermatan Sulphate for Prevention of Deep Vein Thrombosis in Hip Fracture
- Guidance for the Management of Patients with Vascular Disease or Cardiovascular Risk Factors and COVID-19: Position Paper from VAS-European Independent Foundation in Angiology/Vascular Medicine
- Low drug levels and thrombotic complications in high‐risk atrial fibrillation patients treated with direct oral anticoagulants
- Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism
- Risks factors for highly unstable response to oral anticoagulation: a case‐control study